Allianz Asset Management’s Medicines Co MDCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-372,944
Closed -$31.7M 2857
2019
Q4
$31.7M Buy
372,944
+324,415
+668% +$21.6M 0.03% 585
2019
Q3
$2.4M Buy
48,529
+3,610
+8% +$144K ﹤0.01% 1757
2019
Q2
$1.64M Sell
44,919
-1,942
-4% -$63.4K ﹤0.01% 1949
2019
Q1
$1.31M Buy
46,861
+18,478
+65% +$436K ﹤0.01% 1993
2018
Q4
$543K Sell
28,383
-47,462
-63% -$1.1M ﹤0.01% 2242
2018
Q3
$2.27M Sell
75,845
-29,950
-28% -$1.13M ﹤0.01% 1888
2018
Q2
$3.88M Sell
105,795
-203,680
-66% -$6.62M ﹤0.01% 1642
2018
Q1
$10.2M Buy
309,475
+171,875
+125% +$5.37M 0.01% 1249
2017
Q4
$3.76M Buy
137,600
+42,783
+45% +$1.32M ﹤0.01% 1759
2017
Q3
$3.51M Hold
94,817
﹤0.01% 1787
2017
Q2
$3.65M Sell
94,817
-1,170
-1% -$52.1K ﹤0.01% 1732
2017
Q1
$4.7M Buy
95,987
+2,502
+3% +$114K ﹤0.01% 1654
2016
Q4
$3.17M Buy
93,485
+365
+0.4% +$12.9K ﹤0.01% 1797
2016
Q3
$3.53M Sell
93,120
-9,125
-9% -$344K ﹤0.01% 1760
2016
Q2
$3.44M Buy
102,245
+9,475
+10% +$334K ﹤0.01% 1677
2016
Q1
$2.95M Buy
92,770
+10,610
+13% +$347K ﹤0.01% 1638
2015
Q4
$3.07M Hold
82,160
﹤0.01% 1534
2015
Q3
$3.12M Sell
82,160
-19,120
-19% -$671K ﹤0.01% 1453
2015
Q2
$2.9M Buy
101,280
+20,940
+26% +$583K ﹤0.01% 1565
2015
Q1
$2.25M Hold
80,340
﹤0.01% 1486
2014
Q4
$2.22M Buy
80,340
+34,170
+74% +$847K ﹤0.01% 1508
2014
Q3
$1.03M Hold
46,170
﹤0.01% 1659
2014
Q2
$1.34M Sell
46,170
-3,530
-7% -$94.3K ﹤0.01% 1316
2014
Q1
$1.41M Sell
49,700
-287,050
-85% -$9.5M ﹤0.01% 1313
2013
Q4
$13M Buy
336,750
+111,885
+50% +$4M 0.02% 637
2013
Q3
$7.54M Buy
224,865
+31,440
+16% +$1M 0.01% 777
2013
Q2
$5.95M Buy
+193,425
New +$6.47M 0.01% 829

Other funds holding MDCO

Allianz Asset Management's MDCO Position: Q1 2020 in Review

Allianz Asset Management sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 372,944 shares — an estimated $31.7M sold.

Allianz Asset Management first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $31.7M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Allianz Asset Management reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Allianz Asset Management sold 372,944 Medicines Co shares in Q1 2020, an estimated $31.7M.
  • Allianz Asset Management first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
  • Allianz Asset Management's Medicines Co position peaked at $31.7M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Allianz Asset Management's 13F filing for Q1 2020, filed 14 May 2020.